NasdaqGS - Nasdaq Real Time Price
USD
Kiniksa Pharmaceuticals International, plc (KNSA)
92.24
-5.32
(-5.45%)
At close: October 30 at 4:00:01 PM EDT
92.15
-0.09
(-0.10%)
After hours: October 30 at 4:56:02 PM EDT
Trade KNSA on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreLoading chart for KNSA
- Previous Close
97.56 - Open
97.60 - Bid 69.73 x 200
- Ask 117.87 x 200
- Day's Range
91.25 - 98.48 - 52 Week Range
36.56 - 98.48 - Volume
1,320,329 - Avg. Volume
625,017 - Market Cap (intraday)
7.247B - Beta (5Y Monthly) 0.04
- PE Ratio (TTM)
69.88 - EPS (TTM)
1.32 - Earnings Date Oct 27, 2026
- Forward Dividend & Yield -- (0.00%)
- 1y Target Est
109.43 - Motley Fool Rating Bullish
Recent News
View More
Performance Overview
Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
KNSA
123.61%
S&P 500 (^GSPC)
10.73%
1-Year Return
KNSA
147.36%
S&P 500 (^GSPC)
11.11%
3-Year Return
KNSA
488.27%
S&P 500 (^GSPC)
81.91%
5-Year Return
KNSA
787.78%
S&P 500 (^GSPC)
64.59%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 10/30/2026
-
Market Cap
7.25B
-
Enterprise Value
6.69B
-
Trailing P/E
69.88
-
Forward P/E
58.01
-
PEG Ratio (current)
0.36
-
Price/Sales (ttm)
8.12
-
Price/Book (mrq)
10.19
-
Enterprise Value/Revenue
7.07
-
Enterprise Value/EBITDA
45.16
Financial Highlights
Profitability and Income Statement
-
Profit Margin
11.58%
-
Return on Assets (ttm)
9.62%
-
Return on Equity (ttm)
17.59%
-
Revenue (ttm)
945.96M
-
Net Income Avi to Common (ttm)
109.57M
-
Diluted EPS (ttm)
1.32
Balance Sheet and Cash Flow
-
Total Cash (mrq)
568.76M
-
Total Debt/Equity (mrq)
1.11%
-
Levered Free Cash Flow (ttm)
135.87M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
92.24
-5.45%
Mkt Cap
7.247B
Industry
Drug Manufacturers—Specialty & Generic
27.72
+2.93%
Mkt Cap
1.179B
Industry
Drug Manufacturers—Specialty & Generic
35.37
+0.34%
Mkt Cap
4.175B
Industry
Drug Manufacturers—Specialty & Generic
28.86
+0.63%
Mkt Cap
3.622B
Industry
Drug Manufacturers—Specialty & Generic
1.1100
-5.13%
Mkt Cap
134.879M
Industry
Drug Manufacturers—Specialty & Generic
598.72
+0.87%
Mkt Cap
25.68B
Industry
Drug Manufacturers—Specialty & Generic
21.51
+0.75%
Mkt Cap
7.492B
Industry
Drug Manufacturers—Specialty & Generic
3.5000
-3.31%
Mkt Cap
578.34M
Industry
Drug Manufacturers—Specialty & Generic
72.00
-1.59%
Mkt Cap
1.654B
Industry
Drug Manufacturers—Specialty & Generic
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
